Apogee Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Apogee Therapeutics, Inc. (APGE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $4.78 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-02
- Apogee Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $4.78M, a 74.40% increase from fiscal 2024.
- Apogee Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $2.74M, a 124.06% increase from fiscal 2023.
- Apogee Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $1.22M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2025-12-31 | $4.78M 10-K · filed 2026-03-02 |
| 2024-12-31 | $2.74M 10-K · filed 2026-03-02 |
| 2023-12-31 | $1.22M 10-K · filed 2026-03-02 |